Centene (CNC) Divests IlliniCare As Part Of Merger Agreement

 | Dec 02, 2019 09:21PM ET

Centene Corporation (NYSE:CNC) and CVS Health (NYSE:CVS) have inked a deal under which CVS Health will buy Medicaid and Medicare Advantage lines of business owned by Centene in Illinois. The financial terms of this transaction have been kept under wraps.

The divestiture of IlliniCare Health Plan is necessary for Centene to win approval for its WellCare Health Plans (NYSE:WCG) acquisition given business overlap in the region.

Centene had agreed to buy WellCare for $17.3 billion in March 2019. The merger will create a premier healthcare enterprise and a leader in Medicaid, Medicare and the Health Insurance Marketplace. The combined entity will have a wider scale and diversification with more than 12 million Medicaid and around 5 million Medicare members. In total, it will have around 22 million members across 50 U.S. states.

The pending transaction has already received approvals from insurance and health care departments from 26 states though it is still subject to state regulatory approvals and other conditions. The transaction is expected to be completed in the first half of 2020.

The divestiture of the IlliniCare Health plan is the latest development for Centene and the subsequent step in the process of completing the merger with Tampa-based WellCare.

The acquisition of IlliniCare will aid CVS as the latter competes with UnitedHealth Group (NYSE:UNH), Humana (NYSE:HUM) and others in the Medicare Advantage business. Last year, it purchased Aetna (NYSE:AET), which gave it access to the latter’s health insurance business.

The latest buyout will provide CVS with an opportunity to expand its Medicaid and Medicare Advantage presence in Illinois.

Shares of this Zacks Rank #3 (Hold) company have rallied 39.1% quarter to date, outperforming the Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes